Astera Labs (NASDAQ:ALAB) Trading Up 6.7% - Still a Buy?

Key Points

• Astera Labs shares rose 6.7% to $363.46, bringing its market capitalization to approximately $63.1 billion.
• The company reported stronger-than-expected quarterly results, with adjusted EPS of $0.80 versus the $0.69 estimate and revenue of $392.4 million, up 104.5% year over year. Analysts maintain a “Moderate Buy” consensus, though the average price target of $348.33 is below the current share price.
• Insiders sold 592,244 shares worth approximately $209.7 million over the past three months, while institutional investors own 60.47% of the stock.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report)'s share price shot up 6.7% during trading on Tuesday . The company traded as high as $369.15 and last traded at $363.46. 5,392,056 shares traded hands during trading, an increase of 2% from the average daily volume of 5,269,410 shares. The stock had previously closed at $340.74.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the stock. TD Cowen cut their price objective on shares of Astera Labs from $425.00 to $375.00 and set a "hold" rating for the company in a research report on Wednesday, August 5th. Weiss Ratings restated a "hold (c)" rating on shares of Astera Labs in a research report on Tuesday, August 18th. Royal Bank Of Canada lifted their target price on shares of Astera Labs from $425.00 to $500.00 and gave the stock an "outperform" rating in a research note on Wednesday, August 5th. Citigroup reiterated a "buy" rating on shares of Astera Labs in a report on Wednesday, July 29th. Finally, UBS Group reissued a "neutral" rating and set a $425.00 price target on shares of Astera Labs in a research note on Wednesday, August 5th. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $348.33.

Astera Labs Stock Performance

The firm has a market capitalization of $63.06 billion, a price-to-earnings ratio of 179.93 and a beta of 3.77. The business has a fifty day moving average price of $302.90 and a 200 day moving average price of $268.04.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm's revenue was up 104.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, analysts expect that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Insider Transactions at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction that occurred on Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the transaction, the director directly owned 253,863 shares of the company's stock, valued at $71,114,642.19. The trade was a 41.89% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 90,630 shares of the business's stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the sale, the chief operating officer owned 1,119,038 shares of the company's stock, valued at approximately $380,864,583.30. This represents a 7.49% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 592,244 shares of company stock valued at $209,729,973 in the last three months. 10.40% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the stock. Keating Financial Advisory Services Inc. acquired a new stake in shares of Astera Labs in the second quarter valued at about $25,000. Archer Investment Corp purchased a new stake in shares of Astera Labs during the 2nd quarter valued at about $30,000. Transamerica Financial Advisors LLC acquired a new position in Astera Labs during the 2nd quarter worth approximately $35,000. Continuum Advisory LLC acquired a new position in Astera Labs during the 2nd quarter worth approximately $37,000. Finally, Johnson Financial Group Inc. purchased a new position in Astera Labs in the 2nd quarter worth approximately $43,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

About Astera Labs

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data-center operators, system manufacturers and other customers connect, expand and manage the high-speed components used in servers, storage systems and networking platforms.

The company's portfolio includes PCI Express (PCIe) retimers and fabric switches, Compute Express Link (CXL) memory connectivity products, and Ethernet connectivity solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.